Paul Averback's Net Worth
Paul Averback's net worth is estimated to be at least $4,394,000.00 as of 11/25/2024. CoreStreet's estimation of Paul Averback's net worth is based on their sale of stock and current holding of stock.
Paul Averback is CEO at Nymox Pharmaceutical Corp. They have executed at least 2 trades of stock as per SEC Form 4 filings. Their most recent trade was for 1,687,600 units of NYMX stock on 10/29/2018. Their biggest sale was on 10/29/2018 when they sold 1,687,600 units of Nymox Pharmaceutical Corp stock for $4,219,000.00. They typically trade 2 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $4,394,000.00
Most recent insider trade:
- Oct. 29, 2018
Paul Averback's Insider Trading History
| Nymox Pharmaceutical Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 29, 2018 | CEO | 1,687,600 | $2.50 | Sell | $4,219,000.00 |
Oct. 26, 2018 | CEO | 100,000 | $1.75 | Sell | $175,000.00 |